Brain-Machine Interface Stocks Tumble as HEARTCARE-B Leads Losses

Brain-machine interface concept stocks are taking a hit today, with HEARTCARE-B leading the selloff. The sector, which has attracted significant investor attention as a cutting-edge technology space, is experiencing notable losses across the board. This downturn reflects broader market volatility and shifting investor sentiment around emerging biotech and neural interface companies. The decline comes as investors reassess valuations in the high-growth medical technology space.